Hiroaki Ikezaki1, Norihiro Furusyo2, Takeshi Ihara3, Takeo Hayashi3, Kazuya Ura3, Satoshi Hiramine3, Fujiko Mitsumoto3, Koji Takayama3, Masayuki Murata3, Takuji Kohzuma4, Masumi Ai5, Ernst J Schaefer6, Jun Hayashi7. 1. Department of General Internal Medicine, Kyushu University Hospital, Fukuoka 8128582, Japan; Cardiovascular Nutrition Laboratory, Jean Mayor USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA 02111, USA. 2. Department of General Internal Medicine, Kyushu University Hospital, Fukuoka 8128582, Japan. Electronic address: furusyo@gim.med.kyushu-u.ac.jp. 3. Department of General Internal Medicine, Kyushu University Hospital, Fukuoka 8128582, Japan. 4. Diagnostic Department, Asahi-Kasei Pharma, Tokyo 1018101, Japan. 5. Department of Insured Medical Care Management, Tokyo Medical and Dental University Hospital, Tokyo 1138510, Japan. 6. Cardiovascular Nutrition Laboratory, Jean Mayor USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA 02111, USA. 7. Department of General Internal Medicine, Kyushu University Hospital, Fukuoka 8128582, Japan; Kyushu General Internal Medicine Center, Hara-Doi Hospital, Fukuoka 8138588, Japan.
Abstract
OBJECTIVE: Diabetes mellitus is a major cause of cardiovascular, kidney, neurologic, and eye diseases, and may be preventable in some cases by lifestyle modification. Screening tests for diabetes mellitus include fasting plasma glucose (FPG) and glycated hemoglobin (HbA1c). Our objective was to evaluate the utility of plasma glycated albumin (GA) in the diagnosis of diabetes mellitus. DESIGN AND METHODS: A cross-sectional, community-based population study of 908 non-diabetic Japanese residents was conducted. Of these subjects, 176 with FPG value between 5.5 and 6.9mmol/l, and an HbA1c level of <6.5% received an oral glucose tolerance test (OGTT). RESULTS: The OGTT results were used for the diagnosis of diabetes mellitus using World Health Organization criteria. Receiver operating characteristic (ROC) analyses demonstrated that optimal threshold values for the diagnosis of diabetes in this population were 15.2% for GA and 5.9% for HbA1c, respectively. Using these cutoff levels, the sensitivity of GA at 62.1% for detecting diabetes was the same as that of HbA1c. However the specificity for GA for detecting diabetes was 61.9%, while for HbA1c it was higher at 66.7%. CONCLUSIONS: Our results indicate that the measurement of glycated albumin may serve as a useful screening test for diabetes in a general Japanese population.
OBJECTIVE:Diabetes mellitus is a major cause of cardiovascular, kidney, neurologic, and eye diseases, and may be preventable in some cases by lifestyle modification. Screening tests for diabetes mellitus include fasting plasma glucose (FPG) and glycated hemoglobin (HbA1c). Our objective was to evaluate the utility of plasma glycated albumin (GA) in the diagnosis of diabetes mellitus. DESIGN AND METHODS: A cross-sectional, community-based population study of 908 non-diabetic Japanese residents was conducted. Of these subjects, 176 with FPG value between 5.5 and 6.9mmol/l, and an HbA1c level of <6.5% received an oral glucose tolerance test (OGTT). RESULTS: The OGTT results were used for the diagnosis of diabetes mellitus using World Health Organization criteria. Receiver operating characteristic (ROC) analyses demonstrated that optimal threshold values for the diagnosis of diabetes in this population were 15.2% for GA and 5.9% for HbA1c, respectively. Using these cutoff levels, the sensitivity of GA at 62.1% for detecting diabetes was the same as that of HbA1c. However the specificity for GA for detecting diabetes was 61.9%, while for HbA1c it was higher at 66.7%. CONCLUSIONS: Our results indicate that the measurement of glycated albumin may serve as a useful screening test for diabetes in a general Japanese population.
Authors: Anne E Sumner; Michelle T Duong; Paola C Aldana; Madia Ricks; Marshall K Tulloch-Reid; Jay N Lozier; Stephanie T Chung; David B Sacks Journal: Diabetes Care Date: 2015-12-17 Impact factor: 19.112
Authors: Andre Pascal Kengne; Tandi E Matsha; David B Sacks; Annalise E Zemlin; Rajiv T Erasmus; Anne E Sumner Journal: EClinicalMedicine Date: 2022-05-23
Authors: Arsene F Hobabagabo; Nana H Osei-Tutu; Thomas Hormenu; Elyssa M Shoup; Christopher W DuBose; Lilian S Mabundo; Joon Ha; Arthur Sherman; Stephanie T Chung; David B Sacks; Anne E Sumner Journal: Diabetes Care Date: 2020-08-14 Impact factor: 19.112